NEWS

/NEWS

Private Client Services Partner Sharon Soloff Joins FisherBroyles in New York

April 23rd, 2019|FisherBroyles News|

FisherBroyles, LLP, the first and world’s largest distributed law firm partnership, is pleased to announce the addition of Sharon B. Soloff as a partner in the firm’s New York City office and Private Client Services, [...]

R. Mark Halligan, Author/Contributor: Intellectual Property Due Diligence in Corporate Transactions: Investment, Risk Assessment and Management

April 22nd, 2019|FisherBroyles News, Intellectual Property|

R. Mark Halligan, Author/Contributor: Intellectual Property Due Diligence in Corporate Transactions: Investment, Risk Assessment and Management by L.M. Brownlee, published by Thompson Reuters (2019 Edition)

FisherBroyles Employment Partner, Amy Epstein Gluck, Quoted About Rumors and Sex Stereotyping as Sexual Harassment

April 17th, 2019|Employment Law, FisherBroyles News|

FisherBroyles Employment Partner, Amy Epstein Gluck, quoted in Material Handling & Logistics on April 9, 2019, in article entitled "Office Gossip Can Be Sexual Harassment." You can read the article here.

Feds Take Down $1.2 Billion Telemedicine and DME Fraud Scheme

April 12th, 2019|FisherBroyles News, Health Care, Pharmacy Law|

Twenty-four CEOs, COOs, doctors, and others have been charged in a Medicare fraud scheme that cost the federal health care program over $1 billion. Dubbed “Operation Brace Yourself,” the nationwide takedown was led by a [...]

Labor & Employment Partner and Litigator Gordon Berger Joins FisherBroyles in Atlanta

April 12th, 2019|FisherBroyles News|

FisherBroyles, LLP, the first and world’s largest distributed law firm partnership, is pleased to announce the addition of Gordon M. Berger as a partner in the firm’s Atlanta office and Labor & Employment and Litigation [...]

FDA Schedules Hearings on Cannabis Regulation

April 11th, 2019|FisherBroyles News, Health Care, Pharmacy Law|

On April 2, 2019, the U.S. Food and Drug Administration issued a public hearing notice and a press release from the Commissioner to announce FDA’s interest in hearing from cannabis-industry stakeholders on the “safety, manufacturing, [...]